A very timely meta-analysis on Omalizumab in chronic spontaneous urticaria
- PMID: 31630754
- DOI: 10.1016/j.aller.2019.10.001
A very timely meta-analysis on Omalizumab in chronic spontaneous urticaria
Comment on
-
Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis.Allergol Immunopathol (Madr). 2019 Nov-Dec;47(6):515-522. doi: 10.1016/j.aller.2019.05.003. Epub 2019 Oct 11. Allergol Immunopathol (Madr). 2019. PMID: 31607407
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical